Treatment composition containing amlodipine series salt and pril medicament

A kind of technology of amlodipine salt and composition, which is applied in the field of combined medicine kits, can solve the problems such as lack of solubility, intractable benzenesulfonic acid, slow onset of amlodipine and the like
CN101653440AInactive Publication Date: 2010-02-24BEIJING ROCK PHARMA

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
BEIJING ROCK PHARMA
Publication Date
2010-02-24
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to an amlodipine series salt, which particularly comprises nicotinate, camsilate, pyroglutamate, L-aspartate, maleate and mesylate. The invention also relates to a pril compoundor a pharmaceutical composition of a medicinal salt of the pril compound and a preparation method thereof, and a drug combination medicine box containing a composition of the amlodipine series salt and a composition of sartan compounds. The composition of the invention comprises the following components: a) a certain amount of an amlodipine salt; b) a certain amount of the pril compound or a medicinal salt of the pril compound; and c) a medicinal carrier or a diluting agent. The composition or the medicine box can be used for treating the patients suffering from hypertension, angina pectoris,atherosclerosis, and / or hypersphyxia and treating the patients (including the human beings) having heart danger symptoms.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The present invention relates to amlodipine series salts, specifically including nicotinate, camphorsulfonate, pyroglutamate, L-aspartate, maleate and methanesulfonate, and the Composition and preparation method thereof, the present invention also relates to a medicine kit comprising the amlodipine series salt composition and the combined drug of pril. The above compositions or kits can be used to treat patients with hypertension, angina pectoris, atherosclerosis, and / or combined hypertension and patients with cardiac risk symptoms (including humans). Background technique

[0002] Hypertension has become one of the main killers endangering human health. At present, the incidence of hypertension in some European and American countries has reached 20%. According to statistics, 43 million people in the United States suffer from hypertension; the average incidence of hypertension in my country is 11.88%, and more than 140 million people in my country suff...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More